Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Calla Health Foundation develops low-cost, portable medical devices and digital platforms to improve access to cervical cancer screening, diagnosis, and treatment—especially in low-resource settings. Their technologies include the Pocket Colposcope/Callascope for self-screening or provider use without a speculum, an injectable polymer-based ablation therapy that does not require electricity/batteries, integrated mHealth software for image capture/storage/AI diagnostics, and an AI system for risk assessment on par with expert physicians. The foundation’s approach empowers midwives/community peers to deliver care where traditional infrastructure is lacking.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calla Health Foundation.